Q3 2026 Chemed Corporation Earnings Call Transcript
Oct 28, 2026 / 02:00PM GMTOperator Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Chemed Corporation third quarter 2026 earnings
CHEMED CORP NEW (CHE) is drawing unusual attention today. Our newswire has captured 18 stories on CHE across 10 sources in the last 36 hours, with AI sentiment reading bullish (avg 59/100).
Chemed Corp shares rose 9.51% to $557.50 on Tuesday. The primary driver was a strong third-quarter earnings report that exceeded consensus estimates, followed immediately by a rating upgrade from Jefferies and a price target increase from Bank of America.
Chemed reported third-quarter 2026 adjusted earnings per share of $6.75, surpassing the consensus estimate of $6.44. Revenue reached $690.9 million, also beating the expected $685.037 million. The company reaffirmed its full-year 2026 adjusted EPS guidance of $25.00 to $25.75, with the high end exceeding the current consensus of $25.49.
Following the release, Jefferies upgraded the stock to Buy from Hold, citing hospice growth and margin gains. Bank of America raised its price target to $555 from $550. The company filed a Form 8-K with the SEC on October 27, 2026, disclosing the results of operations and financial condition.
The stock opened at $521.01, a 2.3% gap up from the prior close of $509.09. It hit a session high of $559.72 at 9:40 AM ET before settling at $557.50. Volume was 0.0 million shares, which is 0.3 times the three-month daily average.
Fundamentals show a market cap of $6.7 billion and a P/E ratio of 25.6. The company has a beta of 0.51 and a dividend yield of 0.55%. The 52-week range is $365.20 to $557.00, meaning the current price is near the top of its annual range. Over the last 8 sessions, the stock had moved only 0.9%, rising from $511.67 to $516.20. Recent insider activity includes six sells totaling $4.8 million over the last 90 days, with no buys recorded. CEO Kevin J. McNamara sold shares on September 28 and September 18, 2026.
Investors will monitor how the stock sustains its position near the 52-week high following the analyst upgrades. The company’s ability to maintain the margin gains cited by Jefferies will be a key factor in future performance.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Oct 28, 2026 / 02:00PM GMTOperator Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Chemed Corporation third quarter 2026 earnings
Chemed Corporation (CHE) Q3 2026 Earnings Call October 28, 2026 10:00 AM EDTCompany ParticipantsHolley Schmidt - Vice President & Assistant...
VITAS revenue surged 12.2% while Roto-Rooter margins compressed from higher costs.
Why is Chemed stock surging today?
Jefferies upgrades Chemed to Buy, sees compounder multiple returning on Q3 beat
Jefferies upgrades Chemed stock rating on hospice growth, margin gains
CHEMED CORP NEW (CHE) is drawing unusual attention today. Our newswire has captured 18 stories on CHE across 10 sources in the last 36 hours, with AI sentiment reading bullish (avg 59/100). The most recent driver: "Q3 2026 Chemed Corporation Earnings Call Transcript" (GuruFocus).
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of CHE coverage reads 59/100 over 18 stories; treat it as a research signal and do your own diligence.
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More on CHE: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier CHE move explainers: 2026-10-28 · 2026-08-28 · 2026-08-27